RealSeq Biosciences
PrivateLast Round
Grant
Aug 15, 2025
Total Funding Raised
$7M
Company Overview
RealSeq Biosciences, Inc. is a biotechnology company that develops RNA fragmentomics technology for real-time disease detection, biomarker discovery, and liquid biopsy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RealSeq Biosciences Comps
Public and private peers based on sector, stage, and business model.
RealSeq Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 15, 2025 | ||||
| Seed | Mar 13, 2024 | ||||
| Seed | Jul 28, 2023 |
Key People
Founding team and executive leadership
RealSeq Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Chemical Angel Network | Seed |
| NIH RADx | Grant |
| Santa Clara Ventures | Seed |
| Santa Cruz Ventures | Seed |
| MEDA Angels | Seed |
| TiE SoCal Angels | Seed |
| Berkeley Angel Network | Seed |
RealSeq Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RealSeq Biosciences's valuation, stock price, and market status.
